about
Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and RehabilitationMolecular diagnostics of neurodegenerative disordersTranscriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease.Differential proteomics analysis of mononuclear cells in cerebrospinal fluid of Parkinson's diseaseAlteration of Basal Ganglia and Right Frontoparietal Network in Early Drug-Naïve Parkinson's Disease during Heat Pain Stimuli and Resting StateNeuroimaging of Parkinson's disease: Expanding views.Dopamine signaling promotes the xenobiotic stress response and protein homeostasisNeuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β PathwayEpigenetic DNA Methylation Profiling with MSRE: A Quantitative NGS Approach Using a Parkinson's Disease Test CaseInverse Association of Parkinson Disease With Systemic Lupus Erythematosus: A Nationwide Population-based StudyExploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr StageCommentary: Evaluation of Models of Parkinson's DiseaseFactors associated with ambulatory activity in de novo Parkinson diseaseUpdate on the treatment of Parkinson’s disease psychosis: role of pimavanserinComplexity of resting-state EEG activity in the patients with early-stage Parkinson’s diseaseEditorial: Molecular Diagnostics in the Detection of Neurodegenerative DisordersNasal neuron PET imaging quantifies neuron generation and degenerationA loss of Pdxk model of Parkinson disease in Drosophila can be suppressed by BuffyQuantitative proteomic analysis of Parkin substrates in Drosophila neurons.Joint feature-sample selection and robust diagnosis of Parkinson's disease from MRI data.Use of a self-rating scale of the nature and severity of symptoms in Parkinson's Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity.Melatonin enhances neural stem cell differentiation and engraftment by increasing mitochondrial function.Parkinson's Disease: From Pathogenesis to PharmacogenomicsProteomic studies associated with Parkinson's disease.Multiple system atrophy: pathogenic mechanisms and biomarkers.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Personalized medicine in Parkinson's disease: Time to be preciseParkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies.SIRT1 mediates salidroside-elicited protective effects against MPP+ -induced apoptosis and oxidative stress in SH-SY5Y cells: involvement in suppressing MAPK pathways.A highly sensitive miR-195 nanobiosensor for early detection of Parkinson's disease.Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis.Clinical utility of visualisation of nigrosome-1 in patients with Parkinson's disease.Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease.Hybrid CMOS-Graphene Sensor Array for Subsecond Dopamine Detection.Cognitive and Neuropsychiatric Features of Early Parkinson's Disease.A meta-analysis of diffusion tensor imaging of substantia nigra in patients with Parkinson's disease.Vocalization development in common marmosets for neurodegenerative translational modeling.Comparative analysis of four disease prediction models of Parkinson's disease.α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity.
P2860
Q26745654-C00C428C-384F-4325-A65A-2785C61764DFQ26786821-DB95C26A-C70D-40B3-B78F-7CA9BF3581A3Q27333599-DEF6ABCE-4F95-4B9F-9259-BC2E197298A6Q28384168-13B1F92C-AA41-4F1F-8059-FDB4D5DA1CB2Q28386521-F09650DF-B0C3-456F-BA25-05849B6D626DQ28387732-E1DE9C70-BD29-4488-8331-72A4AFA30CC1Q28388147-E6C924CF-5BF4-4228-B32F-98199E31D26FQ28390865-19E480BC-3916-4D09-B6DC-6EDD01490D84Q28393074-E4C699E9-A031-47DA-8F57-F1479A2E1CCDQ28394280-52297CF5-0020-41A4-9467-F14B11882018Q28396892-6B45590B-CF91-4D27-AE3B-77A4B656BC93Q28397369-A7BE7D88-648D-4444-A6F8-D5F9715BDDC6Q29048640-53DF4111-0C25-4292-A4CC-BD98D9CF4621Q29048641-FD0250D5-8F63-4021-B01C-BA4F6DDEE313Q29048642-E4A3E060-2321-443E-94D1-8ED3D2C2C88EQ29048643-C05817D9-D8D1-4B47-A88C-B6AD168C8742Q29048644-DCD968CF-9145-4EB5-8FEF-3DFADD7DBBA2Q30352332-BC6F8FD4-1D7F-4DED-8D1A-6FD77E40C6BBQ30844860-10462D24-50E4-4743-9B5D-CACFB4BDA5E5Q31107850-B3403975-B84F-47ED-8354-025A91399471Q33807815-00D05EDE-D84A-4F42-9C0F-3662FC72E1DEQ36351040-23F64BF8-4D58-4C17-9BE5-6CA37A2CD813Q37729129-FD40AB33-CB8C-4E0B-A482-0C3AA0232FF1Q38761409-51796060-1563-42CE-B138-A7A10EDAC01CQ38813304-90AB104D-A08E-44FA-8EE4-18BB0DE0F075Q39010887-3C36E009-AC60-4BDE-BF14-30462AA79846Q39052041-D91CFF62-71FD-499C-B930-90809A492DE6Q41551706-4C932353-250A-41E4-BA65-4E2ACFBDFC14Q42705650-D68E7B33-AA13-4F50-BC0A-3EBAFF02EE44Q46314923-2A15040D-82E8-44CD-B1FE-533FBA934B52Q47274094-810EFD2B-7DC1-477D-AA7E-7A62B003CD98Q47627884-5EDE619B-650C-4E9D-ACA1-2610D65B634CQ47653671-60AD3EF0-5B22-499D-8ED4-56924290B600Q47850781-4FDDCC40-88FB-46BF-895A-2C64BCF2A3A5Q48509902-F63C8B1F-4BE0-4B3D-986D-B3450E4203EEQ48566146-D31D8ECE-22A6-4180-A6E7-DB4BB7FCD18AQ49638209-8D9085AE-BB4D-4166-B267-76DD29FE3371Q49853380-297FA00D-6522-4133-BC29-7990EA6344E9Q50798861-0801B6CF-950C-4D38-BE59-4CBF9FEE4661Q51764708-75CD23E4-A416-4727-BE51-8B91D72CFA8B
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Biomarkers of Parkinson's disease: present and future
@ast
Biomarkers of Parkinson's disease: present and future
@en
Biomarkers of Parkinson's disease: present and future
@en-gb
Biomarkers of Parkinson's disease: present and future
@nl
type
label
Biomarkers of Parkinson's disease: present and future
@ast
Biomarkers of Parkinson's disease: present and future
@en
Biomarkers of Parkinson's disease: present and future
@en-gb
Biomarkers of Parkinson's disease: present and future
@nl
altLabel
Biomarkers of Parkinson’s disease: Present and future
@en
prefLabel
Biomarkers of Parkinson's disease: present and future
@ast
Biomarkers of Parkinson's disease: present and future
@en
Biomarkers of Parkinson's disease: present and future
@en-gb
Biomarkers of Parkinson's disease: present and future
@nl
P2860
P921
P3181
P1433
P1476
Biomarkers of Parkinson's disease: present and future
@en
P2860
P2880
P3181
P356
10.1016/J.METABOL.2014.10.030
P407
P433
P577
2014-10-31T00:00:00Z